Levodopa/Carbidopa Ratiopharm (Levodopa, Carbidopa Monohydrate)

Levodopa is a precursor that crosses the blood‑brain barrier and is converted into dopamine by aromatic L‑amino acid decarboxylase within the central nervous system. The added dopamine compensates for the loss of dopaminergic neurons characteristic of Parkinson's disease, restoring neurotransmission in motor pathways.

The exact dose of Levodopa/Carbidopa is individualized by the prescribing clinician based on disease severity, patient age, weight, response to therapy and any concurrent medications. No standard dose is provided here; the prescriber will adjust the regimen to achieve optimal symptom control while minimizing side effects.

Safety data for Levodopa/Carbidopa in pregnancy and lactation are limited. The drug is generally not recommended unless the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare professional.

To place an enquiry, visit the product page on gnhindia.com, enter the required quantity and submit the request. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Levodopa/Carbidopa is considered the most effective symptomatic therapy for Parkinson's disease because it directly replaces dopamine. Compared with dopamine agonists, it often provides stronger motor improvement but may cause more dyskinesia over time. MAO‑B inhibitors are used as adjuncts to reduce required levodopa doses, while anticholinergics target tremor but have limited efficacy for other symptoms.

The product should be stored below 25 °C (room temperature). Keep the tablets in the original container, protect them from moisture and direct sunlight, and avoid exposure to extreme heat or humidity to maintain potency throughout the shelf‑life.

Levodopa/Carbidopa is taken orally, usually as a tablet. It can be taken with or without food, although high‑protein meals may interfere with absorption. Patients should follow the prescriber’s instructions regarding timing, dosage and whether the medication should be taken in divided doses throughout the day.

Serious adverse reactions include dyskinesia (involuntary movements), severe psychiatric effects such as hallucinations or confusion, marked hypotension that can lead to fainting, and rare occurrences of neuroleptic malignant‑like syndrome. Prompt medical attention is required if any of these symptoms develop.

Patients with a known hypersensitivity to levodopa, carbidopa or any excipients should avoid the drug. It is also contraindicated in individuals with narrow‑angle glaucoma, severe cardiovascular disease, or those taking non‑selective MAO inhibitors. A thorough medical history is essential before initiating therapy.